Lipidio Pharmaceuticals

United States
Wonewoc, Wisconsin, United States, 92130

Company profile

Lipidio Pharmaceuticals company profile

Lipidio Pharmaceuticals is a healthcare company that focuses on advancing a molecule to treat diseases associated with excess body fat. It includes non-alcoholic steatohepatitis, Prader-Willi syndrome, and antipsychotic drug-induced weight gain. The company was founded in 2018 and headquartered in San Diego, California.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
92130
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$20M
Last funding
Series A / $20M / 2022-11-10
Last equity funding
Series A / $20M
Investors
5
Founders
4
Articles
4

Founders and investors

Founders

David BulloughGary AtkinsonJ. Gordon FoulkesRaksha Shah

Investors

3E BioventuresAlethea Capital ManagementJohn MaraganoreNancy ChangThe Foundation for Prader-Willi Research